403 related articles for article (PubMed ID: 30523244)
21. Many inflammatory bowel disease risk loci include regions that regulate gene expression in immune cells and the intestinal epithelium.
Mokry M; Middendorp S; Wiegerinck CL; Witte M; Teunissen H; Meddens CA; Cuppen E; Clevers H; Nieuwenhuis EE
Gastroenterology; 2014 Apr; 146(4):1040-7. PubMed ID: 24333384
[TBL] [Abstract][Full Text] [Related]
22. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
23. Long Noncoding RNA Signatures Induced by Toll-Like Receptor 7 and Type I Interferon Signaling in Activated Human Plasmacytoid Dendritic Cells.
Joslyn RC; Forero A; Green R; Parker SE; Savan R
J Interferon Cytokine Res; 2018 Sep; 38(9):388-405. PubMed ID: 30230983
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of lncRNA NEAT1 suppresses the inflammatory response in IBD by modulating the intestinal epithelial barrier and by exosome-mediated polarization of macrophages.
Liu R; Tang A; Wang X; Chen X; Zhao L; Xiao Z; Shen S
Int J Mol Med; 2018 Nov; 42(5):2903-2913. PubMed ID: 30132508
[TBL] [Abstract][Full Text] [Related]
25. Gene coexpression networks reveal a broad role for lncRNAs in inflammatory bowel disease.
Johnson JL; Sargsyan D; Neiman EM; Hart A; Stojmirovic A; Kosoy R; Irizar H; Suárez-Fariñas M; Song WM; Argmann C; Avey S; Shmuel-Galia L; Vierbuchen T; Bongers G; Sun Y; Edelstein L; Perrigoue J; Towne JE; Hall AO; Fitzgerald KA; Hoebe K
JCI Insight; 2024 Feb; 9(3):. PubMed ID: 38329124
[TBL] [Abstract][Full Text] [Related]
26. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
27. The Emerging Functions of Long Noncoding RNA in Immune Cells: Autoimmune Diseases.
Sigdel KR; Cheng A; Wang Y; Duan L; Zhang Y
J Immunol Res; 2015; 2015():848790. PubMed ID: 26090502
[TBL] [Abstract][Full Text] [Related]
28. Peripheral Lymphocytes of Patients with Inflammatory Bowel Disease Have Altered Concentrations of Key Apoptosis Players: Preliminary Results.
Neubauer K; Woźniak-Stolarska B; Krzystek-Korpacka M
Biomed Res Int; 2018; 2018():4961753. PubMed ID: 30515402
[TBL] [Abstract][Full Text] [Related]
29. The intestinal complement system in inflammatory bowel disease: Shaping intestinal barrier function.
Sina C; Kemper C; Derer S
Semin Immunol; 2018 Jun; 37():66-73. PubMed ID: 29486961
[TBL] [Abstract][Full Text] [Related]
30. Mucosal transcriptomics highlight lncRNAs implicated in ulcerative colitis, Crohn's disease, and celiac disease.
Braun T; Sosnovski KE; Amir A; BenShoshan M; VanDussen KL; Karns R; Levhar N; Abbas-Egbariya H; Hadar R; Efroni G; Castel D; Avivi C; Rosen MJ; Grifiths AM; Walters TD; Mack DR; Boyle BM; Ali SA; Moore SR; Schirmer M; Xavier RJ; Kugathasan S; Jegga AG; Weiss B; Mayer C; Barshack I; Ben-Horin S; Ulitsky I; Beucher A; Ferrer J; Hyams JS; Denson LA; Haberman Y
JCI Insight; 2023 Jul; 8(14):. PubMed ID: 37261910
[TBL] [Abstract][Full Text] [Related]
31. The Role of lncRNAs in Regulating the Intestinal Mucosal Mechanical Barrier.
Chen S; Zhang C; He B; He R; Xu L; Zhang S
Biomed Res Int; 2021; 2021():2294942. PubMed ID: 34820453
[TBL] [Abstract][Full Text] [Related]
32. miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation.
Xu XM; Zhang HJ
World J Gastroenterol; 2016 Feb; 22(7):2206-18. PubMed ID: 26900285
[TBL] [Abstract][Full Text] [Related]
33. Recent understanding of IBD pathogenesis: implications for future therapies.
Kucharzik T; Maaser C; Lügering A; Kagnoff M; Mayer L; Targan S; Domschke W
Inflamm Bowel Dis; 2006 Nov; 12(11):1068-83. PubMed ID: 17075348
[TBL] [Abstract][Full Text] [Related]
34. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
[TBL] [Abstract][Full Text] [Related]
35. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?
Satokari R
Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554
[TBL] [Abstract][Full Text] [Related]
36. Potential roles of neutrophils in regulating intestinal mucosal inflammation of inflammatory bowel disease.
Zhou GX; Liu ZJ
J Dig Dis; 2017 Sep; 18(9):495-503. PubMed ID: 28857501
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory bowel disease: beyond the boundaries of the bowel.
Actis GC; Rosina F; Mackay IR
Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):401-10. PubMed ID: 21651357
[TBL] [Abstract][Full Text] [Related]
38. Immune aspects of the pathogenesis of inflammatory bowel disease.
Hisamatsu T; Kanai T; Mikami Y; Yoneno K; Matsuoka K; Hibi T
Pharmacol Ther; 2013 Mar; 137(3):283-97. PubMed ID: 23103332
[TBL] [Abstract][Full Text] [Related]
39. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.
Souza HS; Tortori CJ; Castelo-Branco MT; Carvalho AT; Margallo VS; Delgado CF; Dines I; Elia CC
Int J Colorectal Dis; 2005 May; 20(3):277-86. PubMed ID: 15503066
[TBL] [Abstract][Full Text] [Related]
40. Role of MiRNAs in Inflammatory Bowel Disease.
Cao B; Zhou X; Ma J; Zhou W; Yang W; Fan D; Hong L
Dig Dis Sci; 2017 Jun; 62(6):1426-1438. PubMed ID: 28391412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
